MedPath

Study to assess the usefulness of a new drug, Dexmedetomidine, for sedation of patients during insertion of a tube in the wind pipe using endoscopy before anaesthesia

Phase 3
Completed
Conditions
Health Condition 1: null- Patients requiring awake fibreoptic intubation prior to induction of general anaesthesia
Registration Number
CTRI/2012/08/002858
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1)Patients undergoing major head and neck surgeries scheduled for an elective nasal awake fibreoptic intubation due to an anticipated difficult airway

2)ASA Physical Status I-II.

Exclusion Criteria

1)Pregnant or lactating females

2)Use of an α-2-adrenoreceptor agonist or antagonist within 14 days

3)Use of an opiod administered orally or intravenously within 1 hr or intramuscularly within 4 hrs

4)Presence of increased intracranial pressure or CSF leak

5)Acute alcohol intoxication

6)Uncontrolled seizure disorder

7)History of acute unstable angina

8)Laboratory in acute MI within past 6wks

9)Heart rate 50 beats per minute

10)Systolic blood pressure 90mmhg

11)Complete heart block unless patient had a pacemaker

12)Liver transaminase level 2 times the upper normal limit.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Ease of intubation:(acceptable score 3 to 6; not acceptable 6): median score and no. of patients <br/ ><br>2)Percentage of patients requiring Midazolam for rescue sedation to achieve or maintain Ramsay Sedation Scale â?¥2 throughout the study. <br/ ><br>3)Patient tolerance of procedure (no. of patients with a tolerance score of 1 or 2) <br/ ><br>4)Patient cooperation (no. of patients with a score of 1) <br/ ><br>Timepoint: Till completion of fibreoptic intubation and induction of general anaesthesia
Secondary Outcome Measures
NameTimeMethod
1)Mean dose of Midazolam required and number of patients in each group requiring resuce midazolam <br/ ><br>2)Haemodynamic instability <br/ ><br>3)Anaesthesiologistâ??s assessment of ease of patient care (either easy or not easy) <br/ ><br>4)Recall of anxiety, pain and the procedure itself during the AFOI.Timepoint: upto 24 hours after the procedure
© Copyright 2025. All Rights Reserved by MedPath